InflaRx shares fall on failure of lead drug to improve debilitating skin disease

first_imgBiotech Log In | Learn More What’s included? Adobe Shares of the German drug maker InflaRx (IFRX) fell sharply Wednesday after its lead drug failed to benefit patients with a debilitating skin disease in a clinical trial.In the Phase 2 clinical trial, InflaRx tested four escalating doses of its injectable antibody drug called IFX-1 against a placebo in 179 patients with hidradenitis suppurativa, a painful skin disease characterized by inflamed hair follicles, mostly found in the armpits and groin. Involvement of the sweat glands within the follicles causes painful, pus-filled boils, nodules, and abscesses. Adam Feuerstein InflaRx shares fall on failure of lead drug to improve debilitating skin disease Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. First 30 days free. GET STARTED Senior Writer, Biotech Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He’s also a co-host of “The Readout LOUD” podcast. GET STARTEDcenter_img What is it? Tags biotechnologydrug developmentrare disease STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. [email protected] @adamfeuerstein By Adam Feuerstein June 5, 2019 Reprints Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. About the Author Reprintslast_img read more

Ofcom reveals final bidders in UK 5G auction

first_img Chris joined the Mobile World Live team in November 2016 having previously worked at a number of UK media outlets including Trinity Mirror, The Press Association and UK telecoms publication Mobile News. After spending 10 years in journalism, he moved… Read more Home Ofcom reveals final bidders in UK 5G auction Previous ArticleNews and WeatherNext ArticleClosing interview: John Hoffman Chris Donkin Ofcom confirmed six companies will take part in an upcoming spectrum auction for bands earmarked for 5G in the UK, after the final deadline for withdrawal elapsed.The parent companies of existing operators EE, O2 UK, Vodafone UK and 3 UK will be joined by regional wireless broadband provider Connexin and Airspan Spectrum Holdings – a venture backed by Japanese conglomerate SoftBank – in the auction process.Bidders will compete for 40MHz of spectrum in the 2.3GHz band – available for LTE use – and 150MHz of 3.4GHz spectrum intended to support the country’s 5G service.Ofcom said it planned to press ahead with the auction “as quickly as possible” with the next stage set to start later this month, after it fought off legal challenges from 3 and EE.Both operators disputed the regulator’s auction rules late in 2017 with 3 claiming spectrum caps imposed on operators did not do enough to address competition concerns, while EE wanted the cap removed completely.Courts ruled in Ofcom’s favour in December 2017 and although EE accepted the decision, 3 took its case to appeal. The appeal was finally rejected in February.Ofcom chief executive Sharon White slammed the action for delaying the auction for commercial interests.Announcing the identity of the qualified bidders, Ofcom spectrum director Philip Marnick said: “We’re pressing ahead with the auction to make these airwaves available as quickly as possible. This will benefit today’s mobile users by providing more capacity for mobile broadband use. It will also pave the way for 5G – allowing operators to launch the next generation of mobile technology.” Vodafone, Safaricom beat MTN to Ethiopia licence 3 UKAirspan Spectrum HoldingsConnexinEEO2 UKOfcomSoftBankVodafone Tags Related Author AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 06 MAR 2018 Las operadoras respaldan el papel de Qualcomm en la RAN abierta Operators back Qualcomm role in open RAN pathlast_img read more